After a strong rally in Asian markets, particularly India, a breather is expected due to high valuations and downward revisions in earnings estimates for fiscal years 2026 and 2027. A shift in global equity flows is occurring, with money moving from developed markets, especially the US, into emerging markets like Asia-Pacific, driven by concerns over US growth and inflation.

Manishi Raychaudhuri favors private sector banks due to potential consumption and investment rebound, alongside consumer discretionary stocks benefiting from tax cuts. Industrials, boosted by infrastructure spending and defense equipment manufacturing, are also promising. While cautious about generics, he sees potential in domestic healthcare, particularly hospitals and diagnostics, driven by increasing urban affluence.

Prostarm Info Systems is launching its IPO soon. The price is set between Rs 95 and Rs 105 per share. The IPO will open on May 27 and close on May 29. The company aims to raise Rs 168 crore through this IPO. Prostarm will use the funds for working capital and debt repayment.

Japan s Nikkei share average fell on Wednesday as traders locked in recent gains and appreciation in the yen sapped demand for exporters.

European stocks retreated from two-month peaks on Wednesday, weighed down by a drop in Julius Baer shares after the Swiss bank revealed credit portfolio charges, while investors kept an eye on U.S. trade developments and tax bill debate.

FIIs raised stakes in 10 mid-cap Nifty500 stocks in Q4 FY25, including IndusInd Bank and UPL, signaling increased interest in India s mid-cap space amid global market participation.

Rohit Srivastava suggests the market is holding gains with sector rotation, eyeing 25,300 on the Nifty. Key levels to watch are 24,494 for Nifty and 54,800 for Bank Nifty, with a potential breakout above 55,650 targeting 58,000-60,000. He favors NBFCs and oil marketing companies, noting better midcap earnings and a bullish outlook on pharma stocks.

As of April 2025, 210 stocks were held by over 100 mutual fund schemes. Of these, 11 stocks rallied over 25% in 2025, reflecting strong investor confidence and institutional support across names like Bajaj Finance, SBI Cards, and Solar Industries.

​Digant Haria sees EMS as a Make-in-India success, with Dixon Technologies leading the charge despite high valuations. ​